Single Cell Technologies to Dissect Heterogenous Immune Cell Therapy Products

Area of Science:

• Life Sciences
• Immunology
• Biotechnology

Background:

• Single cell technologies have revolutionized life sciences research.
• Immune cell therapies, including autologous and allogeneic approaches, are increasingly entering clinical practice.
• Understanding cellular heterogeneity is crucial for effective cell manufacturing.

Purpose of the Study:

• To discuss methods, applications, and considerations for utilizing single cell technologies in immune cell manufacturing.
• To explore how molecular profiling can inform cell product quality and predict clinical outcomes.
• To highlight the potential of these technologies in redefining cell manufacturing processes.

Main Methods:

• Profiling molecular heterogeneity at multiple omics levels (genome, epigenome, transcriptome, proteome, metabolome, antigen receptor repertoire).
• Employing multi-omic approaches for comprehensive cellular analysis.
• Utilizing non-destructive and destructive omics techniques for cell monitoring and potency prediction.

Main Results:

• Single cell data can reveal molecular heterogeneity within cell products.
• Linking omics data to potency readouts and clinical data can identify Critical Quality Attributes.
• Non-destructive methods aid in monitoring cell state and gene editing impacts.
• Combining destructive and non-destructive omics can predict therapeutic potency.

Conclusions:

• Single cell technologies are essential for characterizing immune cell products.
• Identifying Critical Quality Attributes through multi-omic analysis can improve patient outcomes.
• These technologies are set to transform cell manufacturing into a more rapid, cost-effective, and high-throughput process.
• The integration of single cell approaches will enable better detection and response to dynamic cell states in manufacturing.